The article you requested is
Behavioral and Psychopharmacologic Pain Management
J Clin Psychiatry 2012;73(3):401 [book review]
Copyright 2012 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $30
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($129) or print + online ($166 individual).
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
From our regular book review column.
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
Pain has been defined as “an unpleasant experience which we primarily associate with tissue damage or describe in terms of such damage, or both.” Recognition of its importance as an acute signal of impending physical danger led to pain’s being denoted as “the fifth vital sign.” That physicians need to improve their management of both acute and chronic pain was a clear message of the recent Institute of Medicine (IOM) report Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research.